Digital

UCLA looks to Twitter for health trends

UCLA looks to Twitter for health trends

By

Researchers say Twitter could provide critical insight into health needs for hard-to-reach groups.

Cancer center and tech co. test Apple Watch in breast-cancer patients

Cancer center and tech co. test Apple Watch in breast-cancer patients

By

Parties in the effort say the novelty of wearing an Apple Watch, along with a newly developed app, may help clinicians refine treatment plans and patient support.

Hints from the pros: Social media done well requires risk

Hints from the pros: Social media done well requires risk

By

Successful social-media engagement is not about the perfect picture or a tightly controlled brand. Instead, panelists at the Hub Convene conference indicated it's a matter of letting the audience take hold

Five things for pharma marketers to know: Tuesday, May 12

Five things for pharma marketers to know: Tuesday, May 12

By

Mylan considers higher bid for Perrigo; Boehringer Ingelheim partners with health system on COPD; EMD Serono's experimental cancer drug gets Fast Track status

Is Digital Marketing a Dead-End Job?

Is Digital Marketing a Dead-End Job?

Either we need to stop calling it digital marketing (because digital is baked into business) and just consider it marketing. If we feel like we can't, then digital might very well be a dead-end job.

Apple Watch Changes the Health Wearables Game

Apple Watch Changes the Health Wearables Game

An early review of the Apple Watch

Diabetes advocate Manny Hernandez joins digital health firm

Hernandez is known for his ability to bring together patients and pharma. He joined Livongo Health to aid the firm's user experience.

Fit4D wins MM&M shark-tank challenge

Fit4D wins MM&M shark-tank challenge

By

Four start-ups presented their business models to pharma executives during the MM&M Transforming Healthcare conference on Thursday in New York City.

Five things for pharma marketers to know: Wednesday, April 22

Five things for pharma marketers to know: Wednesday, April 22

By

Study finds vaccines still not linked to autism; investments in healthcare start-ups hit record high this year; biosimilars are already bearing down on prices overseas

Biogen, PatientsLikeMe use Fitbit to better understand MS

Biogen, PatientsLikeMe use Fitbit to better understand MS

By

The drugmaker and patient network teamed up to establish a formal framework for deploying activity trackers for patients with MS and for capturing that data.

ResearchKit: A Medical Research Revolution?

ResearchKit: A Medical Research Revolution?

Apple is putting the power of clinical trials in our pockets with ResearchKit.

FDA open-data platform gains traction

FDA's application programming interfaces, or openFDA, reached 6,000 users less than a year after its launch.

Drugmakers weigh more use of digital

Drugmakers weigh more use of digital

By

The pharma sales model increasingly relies on key account managers rather than sales reps.

Health Data Ushers in a New Era for Healthcare Communicators

Health Data Ushers in a New Era for Healthcare Communicators

Patients benefit when they can directly access their health data. Studies suggest that direct patient access to healthcare information could improve patient participation in healthcare and possibly quality.

University develops program to turn social media into adverse drug reaction data

A group of computer science and engineering students at the Carlos III Universidad in Madrid used natural language processing techniques to translate social-media and forum posts into adverse drug reaction data.

What's Your Connected Health Strategy?

What's Your Connected Health Strategy?

At SXSW, for the first time, health wasn't a breakout topic, but rather a "break-in" topic that had the attention of just about every presenter and attendee.

23andMe will harness genetic research in new drug discovery unit

23andMe will harness genetic research in new drug discovery unit

By

The personal genetics company created a therapeutics group to extricate new drug targets from its research database.

Survey suggests doctors increasingly look for digital engagement

A new survey from Cegedim Relationship Management claims that digital tools are being underutilized and represent an opportunity to meet the demands of HCPs.

Collaboration forms to fight misinformation in genetic testing

A recent analysis found that most websites touting personal cancer medicine failed to provide risk data, while an insurer and a health system team up to develop best practices to improve the "how" of genetic testing.

Five things for pharma marketers to know: Friday, March 6

Five things for pharma marketers to know: Friday, March 6

By

FDA approves the first biosimilar, judge rules that FDA panel members had conflicts of interest, and a new venture will evaluate the effectiveness of digital health technologies.

Poll shows all ages seek digital health tools

Poll shows all ages seek digital health tools

By

Millennials and baby boomers have a lot of common: a desire for technology that supports health priorities.

Vice: Health search queries are being tracked

Search queries for common diseases on the websites for the CDC and WebMD, among others, are being sent to third-party corporations.

Five things for pharma marketers to know: Tuesday, February 24

Five things for pharma marketers to know: Tuesday, February 24

By

FDA approves Novartis's Farydak for multiple myeloma; Shire acquires rare-disease drug for $70 million; FTC fines melanoma app marketers.

FDA Draft Guidance on General Wellness Devices: A Primer

FDA Draft Guidance on General Wellness Devices: A Primer

A treatise on understanding the FDA's latest guidance of low-risk general wellness products.

Five things for pharma marketers to know: Thursday, February 19

Five things for pharma marketers to know: Thursday, February 19

By By

Lilly delays Phase-III cholesterol drug results; PatientsLikeMe and Walgreens team up for "drug reaction reviews"; Roche skin-cancer drug receives Priority Review.

Pharma Marketers: Adopt Principles of Sharing Economy to Catalyze New Growth

Pharma Marketers: Adopt Principles of Sharing Economy to Catalyze New Growth

How the adoption of principles from recent, successful start ups can be applied to pharma marketing.

Apple Watch ditches advanced health features: WSJ

Citing an unnamed source, the paper reports that Apple has abandoned some of the more advanced health monitoring features in its upcoming device, the Apple Watch.

Five things for pharma marketers to know: Wednesday, January 28

Five things for pharma marketers to know: Wednesday, January 28

By By

Doximity professional network now includes financial data; Pfizer settles class-action lawsuit; researchers hope to use temporary tattoos to identify glucose levels.

P&G's Zzzquil accused of sexist tweet

The nighttime sleep aid's Twitter account wrote "Sleep LIKE he finally proposed," last week, a sentiment which didn't resonate positively with the feed's followers.

The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.

Email Newsletters